Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
Mark DonnellyDorothee DrieverÉanna J RyanJessie A ElliottJohn FinneganDeirdre McNamaraIan MurphyKevin C ConlonPaul C NearyDara O KavanaghJames M O'RiordanPublished in: Inflammatory bowel diseases (2023)
Myosteatosis is associated with nutritional impairment and predicts increased overall postoperative morbidity following resection for CD. Despite its association with specific increased postoperative risks, increased adiposity does not increase overall morbidity, reflecting preservation of nutritional status and relatively more quiescent disease phenotype. Impaired muscle mass and function represent an appealing target for patient optimization to improve outcomes in the surgical management of CD.